Siaton, James .

HRN: 25-76-31  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2024
AMPICILLIN 250MG (VIAL)
11/15/2024
11/22/2024
IV
200mg
Q6h
PCAP C
Waiting Final Action 
11/15/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/15/2024
11/22/2024
IV
60mg
Q24h
PCAP C
Waiting Final Action 
11/19/2024
CEFUROXIME 750MG (VIAL)
11/19/2024
11/25/2024
IV
135 Mg
Q8H
PCAP C
Waiting Final Action 
11/19/2024
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
11/19/2024
11/23/2024
ORAL
1 Ml
OD
PCAP C
Waiting Final Action 
11/20/2024
CEFTRIAXONE 1G (VIAL)
11/20/2024
11/27/2024
IV
400mg
Q24h
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: